EMERGENT BIOSOLUTIONS INC (EBS) Stock Cash Flow
NYSE:EBS • US29089Q1058
Current stock price
8.39 USD
+0.54 (+6.88%)
At close:
8.22 USD
-0.17 (-2.03%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 52.60M | -190.60M | -760.50M | -223.80M | 230.90M | |||
| Depreciation Amortization | 95.80M | 108.80M | 125.10M | 143.30M | 123.80M | |||
| Income Taxes - Deferred | -4.00M | -5.50M | -8.90M | -19.00M | 46.90M | |||
| Change In Working Capital | -25.50M | 85.10M | -75.10M | -30.70M | -156.40M | |||
| Interest Paid | 49.70M | 64.00M | 68.30M | 33.00M | 30.40M | |||
| Taxes Paid | 40.00M | 26.50M | 52.80M | 6.20M | 71.60M | |||
| Other non cash items | 51.70M | 60.90M | 513.10M | 64.90M | 75.90M | |||
| OPERATING CASH FLOW | 170.60M | 58.70M | -206.30M | -34.10M | 321.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -13.80M | -22.90M | -57.90M | -359.50M | -225.00M | |||
| Other Investing Activity | 83.20M | 148.10M | 270.20M | -21.80M | N/A | |||
| INVESTING CASH FLOW | 69.40M | 125.20M | 212.30M | -381.30M | -225.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -108.70M | -198.40M | -543.40M | 564.20M | -35.90M | |||
| Stock Issued/Repurchased | -22.70M | 24.20M | 10.20M | -77.10M | -90.10M | |||
| Other Financing Activity | -5.20M | -15.80M | -2.50M | -5.90M | -15.00M | |||
| FINANCING CASH FLOW | -136.60M | -190.00M | -535.70M | 481.20M | -141.00M | |||
| Exchange Rate Effect | 100.00K | 0.00 | -1.20M | 500.00K | -300.00K | |||
| CHANGE IN CASH | 103.50M | -6.10M | -530.90M | 66.30M | -45.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 170.60M | 58.70M | -206.30M | -34.10M | 321.10M | |||
| Capital Expenditure | -13.80M | -22.90M | -57.90M | -359.50M | -225.00M | |||
| FREE CASH FLOW | 156.80M | 35.80M | -264.20M | -393.60M | 96.10M | |||
All data in USD